Placebo
ACP-103-045
Phase 3 small_molecule completed
Quick answer
Placebo for Dementia-related Psychosis is a Phase 3 program (small_molecule) at Acadia Pharmaceuticals B.V. with 1 ClinicalTrials.gov record(s).
Program details
- Company
- Acadia Pharmaceuticals B.V.
- Indication
- Dementia-related Psychosis
- Phase
- Phase 3
- Modality
- small_molecule
- Status
- completed